Project Grant R01AR083155

Award Date 6/1/24
Completion Date 5/31/29
Dollars Obligated $1.6M
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Durham, NC 27708, USA
Similar Awards
This Project Grant award of $473,377 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) supports research aimed at improving skeletal muscle regeneration through the use of human pluripotent stem cells (hPSCs). The key objectives are to: 1) Investigate how muscle cells develop from hPSCs and the role of co-factors in promoting functional maturation; 2) Establish an in vitro...
This $177,872 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) aims to study the mechanisms of interaction between human induced pluripotent stem cell (hiPSC)-derived endothelial cells (ECs) and skeletal myogenic progenitor cells (MPCs) both in vitro and in vivo. The key objectives are to: a) investigate the paracrine effects of hiPSC-ECs on the activity...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will support research to investigate the novel role of HOX-expressing interstitial cells in skeletal muscle growth, homeostasis, and regeneration. The $557,357 award to the University of Wisconsin-Madison will fund a 5-year research project to utilize genetic tools and multi-omic approaches to...
This $420,883 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will support research to improve muscle regeneration and restore function following serious traumatic injuries. The University of Missouri System, the prime recipient, will leverage its expertise in microvascular imaging, muscle biology, and biomaterials to investigate the role of fibroadipogenic...
This five-year, $649,659 National Science Foundation Engineering Project Grant will support research at the Massachusetts Institute of Technology to advance fundamental understanding of the tissues that produce voluntary movement in humans and other biological creatures. Specifically, the grant will fund experiments studying how mechanical signaling coordinates assembly, maturation and repair at the neuromuscular interface in both physiological and pathological states. The principal investigator...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $439,791 Project Grant (R01AR085116) to The University of Texas Southwestern Medical Center (UT Southwestern) to investigate the molecular mechanisms of myoblast fusion, a critical process for skeletal muscle development and regeneration. The research, conducted under the Arthritis, Musculoskeletal and Skin Diseases Research federal grant program (CFDA 93.846), aims to obtain a deeper mechanistic...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $692,292 to the Children's Research Institute in Washington, D.C. to conduct research on understanding the regulation of pediatric muscle regeneration and its implications for treating muscle diseases like Duchenne muscular dystrophy (DMD). The research aims to address knowledge...
This $485,375 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports the development and testing of a 3D engineered muscle tissue model to examine the metabolic response to muscle contraction in the context of aging. The award aims to: 1) Investigate the mitochondrial mechanisms underlying the decreased metabolic response to muscle contraction in aged human 3D engineered muscle tissue, and 2) Characterize the effect of aging on adaptation to...
This Project Grant award, provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will fund research to investigate the role of netrin signaling in regulating muscle stem cell quiescence and activation. The $626,483 award, effective from August 1, 2024 to May 31, 2026, will support the Icahn School of Medicine at Mount Sinai in conducting in vivo and ex vivo studies to...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will provide $201,960 to the University of Vermont & State Agricultural College to develop a novel zebrafish model system for studying the function of myosin-binding protein C (MyBP-C), a key regulator of muscle contractility. The project aims to create "designer MyBP-C" zebrafish by...

ENGINEERING HETEROCELLULAR HUMAN SKELETAL MUSCLE TISSUES TO RECREATE AND STUDY NATIVE STEM CELL NICHE FUNCTION - HEALTHY SKELETAL MUSCLE IS CAPABLE OF MULTIPLE CYCLES OF REGENERATION IN RESPONSE TO SMALL TEARS THAT OCCUR DURING DAILY ACTIVITY AND EXERCISE. CENTRAL TO THIS REGENERATIVE CAPACITY ARE THE MUSCLE STEM CELLS TERMED SATELLITE CELLS (SCS), WHICH RESIDE IN SPECIALIZED TISSUE "NICHES" AND IN RESPONSE TO INJURY ACTIVATE, PROLIFERATE, AND FUSE TO FORM NEW OR REPAIR DAMAGED MUSCLE FIBERS. DYSREGULATION OF SC NICHE LEADS TO LOSS OF MUSCLE REPAIR ABILITY FOUND IN AGING, CONGENITAL NEUROMUSCULAR AND METABOLIC DISORDERS, AND ACQUIRED DISEASES SUCH AS CANCER OR VOLUMETRIC MUSCLE LOSS. FUNCTION OF HEALTHY SC NICHE IS REGULATED BY A COMPLEX INTERPLAY OF BIOCHEMICAL AND BIOPHYSICAL INPUTS FROM SURROUNDING EXTRACELLULAR MATRIX, MUSCLE FIBERS, BLOOD VESSELS, NEURONS, IMMUNE AND CONNECTIVE TISSUE CELLS. WHILE SPECIFIC ROLES OF THESE REGULATORY MECHANISMS ARE DIFFICULT TO DISSECT IN VIVO, ENGINEERED 3- DIMENSIONAL (3D) SKELETAL MUSCLE TISSUES OFFER THE OPPORTUNITY TO RECAPITULATE AND SYSTEMATICALLY STUDY SC NICHE FUNCTION IN VITRO. HOWEVER, CURRENT ENGINEERED MUSCLE TISSUES LACK THE COMPLEX HETEROCELLULAR MILIEU OF NATIVE MUSCLE, ALONG WITH THE FACTORS KNOWN TO CONTROL SC NICHE HOMEOSTASIS AND RESPONSE TO INJURY. OUR GROUP HAS BEEN THE FIRST TO ENGINEER 3D FUNCTIONAL HUMAN SKELETAL MUSCLE TISSUES ("MYOBUNDLES") FROM PRIMARY MYOBLASTS AND INDUCED PLURIPOTENT STEM CELLS AND UTILIZE THEM FOR STUDIES OF MUSCLE EXERCISE, METABOLISM, INFLAMMATION, DRUG RESPONSE, AND MODELING OF CONGENITAL MUSCLE DISEASES. WHILE IN HUMAN MYOBUNDLES MADE OF MYOGENIC CELLS, SCS ATTAIN A PERI-MYOFIBER POSITION, QUIESCENT PHENOTYPE, AND HETEROGENEITY AKIN TO THOSE OF NATIVE SCS IN VIVO, THEIR REGENERATIVE RESPONSE IS LESS ROBUST THAN OBSERVED IN NATIVE SKELETAL MUSCLE. WE THUS PROPOSE TO INCREASE THE CELLULAR COMPLEXITY OF SC NICHES IN MYOBUNDLES TO APPROXIMATE THAT OF NATIVE SKELETAL MUSCLE BY INCORPORATING CAPILLARY NETWORKS AND FUNCTIONAL MOTONEURONS KNOWN TO SUPPORT NICHE FUNCTION IN VIVO. THE IMPROVED BIOMIMETIC NATURE OF VASCULARIZED AND INNERVATED MYOBUNDLES DEVELOPED IN THIS PROJECT WILL ALLOW US TO FURTHER INVESTIGATE CELL-SPECIFIC ROLES AND CROSS-CELLULAR INTERACTIONS REGULATING THE HUMAN SC NICHE MAINTENANCE, HETEROGENEITY, AND RESPONSE TO MUSCLE EXERCISE AND INJURY. ULTIMATELY, WE ANTICIPATE THAT THIS NOVEL HETEROCELLULAR MODEL OF ENGINEERED SKELETAL MUSCLE TISSUE WILL ENABLE IMPROVED IN VITRO MODELING, MECHANISTIC, AND THERAPEUTIC STUDIES OF HUMAN MUSCLE DISORDERS INVOLVING DYSREGULATION OF SC NICHE.

Posted 5/16/24, 12:00 AM